Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reuters Company Research

Reuters Company Research

posted on Jul 14, 2008 01:52PM

Reuters lowered one of it's four compnents of the PTSC rating today.

Until today, Reuters had rated all 4 components in its rating system as "Outperform" - it's highest rating.

Although the overall composite rating remains "Outperform" one component of the 4 has dropped to "Underperform" - Reuters' lowest rating. Not surprisingly, it was the "Technical Factors" component that was down rated.

Reuters says: "The “Technical Factor” component of the rating is based on analyses of share price movements over a variety of time periods. We compare performance characteristics of individual stocks with those of all the others we rate. Generally speaking, our goal is to favor up-trending shares that have experienced recent corrections and de-emphasize down-trending shares experiencing uncharacteristic periods of strength."







Share
New Message
Please login to post a reply